Kinzbio Wins INCATE Stage II Award

Kinzbio has been awarded the Stage II Award by INCATE (the incubator for Antibacterial Therapies in Europe). This is the first time a non-european company receives this distinction.

​

This recognition reflects both Kinzbio’s scientific innovation and a shared commitment with INCATE to address one of the most pressing global health challenges of our time. With this milestone, Kinzbio moves closer to transforming how resistant infections are treated and prevented.